期刊文献+

靶向DAL-1基因的shRNA表达载体的构建与鉴定 被引量:1

Construction and identification of specific shRNA interference plasmid vector targeted to DAL-1 gene mRNA
下载PDF
导出
摘要 目的:建立DAL-1稳定抑制的非小细胞肺癌(NSCLC)细胞实验模型.方法:构建靶向DAL-1的shRNA表达载体转染NSCLC细胞株,筛选出阳性克隆,在mRNA和蛋白质水平鉴定其抑制效率,最终得到DAL-1稳定抑制的细胞株.结果:通过双酶切鉴定和测序鉴定构建的shRNA表达载体序列正确,T4表达载体在mRNA和蛋白质水平能有效抑制DAL-1的表达,抑制率分别为(87.4±2.0)%和(82.7±2.1)%.结论:成功设计并构建了靶向DAL-1的shRNA表达载体,建立了DAL-1稳定抑制的NSCLC细胞株,为进一步研究DAL-1在NSCLC细胞中的作用提供了实验模型. AIM: To build the experimental NSCLC cellular model in which expression of DAL-1 is steadily inhibited. METHODS: Specific shRNA interference plasmid vectors targeted to DAL-1 mRNA was constructed. The positive clones were screened by double-enzyme digestion and DNA sequencing. The expression at levels of DAL-I mRNA and protein was detected with Q-PCR and Western blot to screen the clones in which DAL-1 was steady inhibited. RESULTS: The sequences of the constructs were confirmed by double-enzyme digestion and DNA sequencing. The expressions of DAL-1 mRNA and DAL-1 protein of T4 group decreased significantly and the inhibition rate was (87.4 ± 2.0 )% and ( 82. 7 ± 2. 1 ) % respectively. CONCLUSION: Specific shRNA interference plasmid vector targeted to DAL-1 gene mRNA is successfully designed and constructed. NCI-H460/T cell line with stable inhibition of DAL-1 expression is established successfully, which provides experimental models for further study of the roles of DAL-A in NSCLC cells.
出处 《第四军医大学学报》 北大核心 2009年第2期129-133,共5页 Journal of the Fourth Military Medical University
基金 广东省科技计划项目(2004B30601011) 广东省自然科学基金(7003068) 广州市科技计划项目(61002)
关键词 非小细胞肺 RNA干扰 DAL-1 carcinoma, non-small cell lung RNA interference DAL-1
  • 相关文献

参考文献13

  • 1Oliaro A, Filosso PL, Cavallo A, et al. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system [ J ]. Eur J Cardiothorac Surg, 2008,34 (2) :438 - 443.
  • 2Tran YK, Bogler O, Gorse KM, et al. A novel member of the NF2/ ERM/4. 1 superfamily with growth suppressing properties in lung cancer[J]. Cancer Res, 1999, 59( 1 ) :35 -43.
  • 3Gutmann DH, Donahoe J, Perry A, et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas[ J ]. Hum Mol Genet, 2000, 9 ( 10 ) : 1495 - 1500.
  • 4Charboneau AL, Singh V, Yu T, et al. Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells[J]. Int J Cancer, 2002,100(2) :181 - 188.
  • 5Sun CX, Robb VA, Gutmann DH. Protein 4.1 tumor suppressors: Getting a FERM grip on growth regulation [ J ]. J Cell Sci, 2002, 115:3991 -4000.
  • 6Kikuchi S, Yamada D, Fukami T, et al. Promoter methylation of DAL-1/4.1 B predicts poor prognosis in non-small cell lung cance [ J ]. Clin Cancer Res, 2005, 11 (8) :2954 - 2961.
  • 7Wang QZ, Lv YH, Diao Y, et al. The design of vectors for RNAi delivery system[J]. Curr Pharm Des, 2008, 14(13) :1327 - 1340.
  • 8Uprichard SL. The therapeutic potential of RNA interference [ J ]. FEBS Lett, 2005,31 (26) :5996-6007.
  • 9Opalinska JB, Gewirtz AM. Nucleic-acid therapeutics : Basic principles and recent applications[ J]. Nat Rev Drug Discov, 2002, (7) :503 -514.
  • 10Chen JS, Lan K, Hung MC, et al. Strategies to target HER2/ neu over-expression for cancer therapy [ J ]. Drug Resist Updat, 2003,6(3) :129 - 136.

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部